Target intelligence / Profile preview

NFYC pseudogene 2 (NFYCP2)

Target
NFYCP2
Molecular classification
Other (Pseudogene)
01

Overview

NFYC pseudogene 2 is a processed pseudogene and does not encode a functional protein. It is related by sequence similarity to the NFYC gene, which encodes a subunit of a trimeric transcription factor (NF-Y) that binds to CCAAT motifs in gene promoters. As a pseudogene, NFYCP2 lacks the capacity to produce a functional transcript or protein and is not implicated in disease mechanisms or therapeutic targeting. Although some pseudogenes may have regulatory functions (e.g., as competing endogenous RNAs)[1][11], there is no evidence that NFYCP2 has such a function or clinical relevance. This locus is cataloged for genomic annotation but is not considered a legitimate drug target[5][7][9]. NFYCP2 is not a therapeutic target; it is a non-functional genomic element. The term “pseudogene” indicates it is not expected to play a direct role in coding for functional proteins or to be suitable for pharmacological targeting[5][7][9]. There is nothing to suggest alternative splicing, translation, or known disease association.

Other names
NFYC Pseudogene 2

Beyond the preview

Go deeper on NFYC pseudogene 2 (NFYCP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NFYC pseudogene 2 (NFYCP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call